Genitourinary Syndrome of Menopause in Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

November 29, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Genitourinary Syndrome of Menopause (GSM)Breast Cancer Female
Interventions
COMBINATION_PRODUCT

Multimodal pelviperineal physioterapy group

"The multimodal PPT protocol includes:~Pelvic Floor Muscle Training (PFMT): This component includes techniques to raise awareness of the pelvic floor, incorporating both manual and instrumental intravaginal techniques.~Non-Ablative Radiofrequency Therapy (Model: RNG, INDIBA): Applied during all eight sessions, with each session lasting 25 minutes.~Therapeutic Pelvic Health Education: Designed to empower participants with knowledge about their condition and the pelvic-perineal area. This educational intervention aims to enhance understanding, promote self-care, and encourage behaviours that alleviate symptoms associated with GSM"

DEVICE

Laser CO2 Therapy group

"The fractional laser application will be delivery with the following probes:~90° Probe for Incontinence: Maximum power of 40W; 360° Probe for Vaginal Atrophy: Maximum power of 40W and Right-Angle Probe for Vulvar Atrophy: Maximum power of 24W."

Trial Locations (1)

28034

RECRUITING

Hospital Universitario Ramón y Cajal, Madrid

All Listed Sponsors
lead

University of Alcala

OTHER